ATE360209T1 - Nachweis viraler agentien in brustmilchkanälen und antivirale therapie - Google Patents

Nachweis viraler agentien in brustmilchkanälen und antivirale therapie

Info

Publication number
ATE360209T1
ATE360209T1 AT01959626T AT01959626T ATE360209T1 AT E360209 T1 ATE360209 T1 AT E360209T1 AT 01959626 T AT01959626 T AT 01959626T AT 01959626 T AT01959626 T AT 01959626T AT E360209 T1 ATE360209 T1 AT E360209T1
Authority
AT
Austria
Prior art keywords
antiviral therapy
detection
breast milk
viral agents
breast
Prior art date
Application number
AT01959626T
Other languages
English (en)
Inventor
David Hung
Original Assignee
Cytyc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytyc Corp filed Critical Cytyc Corp
Application granted granted Critical
Publication of ATE360209T1 publication Critical patent/ATE360209T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01959626T 2000-08-08 2001-08-08 Nachweis viraler agentien in brustmilchkanälen und antivirale therapie ATE360209T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22385700P 2000-08-08 2000-08-08

Publications (1)

Publication Number Publication Date
ATE360209T1 true ATE360209T1 (de) 2007-05-15

Family

ID=22838235

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01959626T ATE360209T1 (de) 2000-08-08 2001-08-08 Nachweis viraler agentien in brustmilchkanälen und antivirale therapie

Country Status (9)

Country Link
US (2) US7132232B2 (de)
EP (1) EP1307746B1 (de)
JP (1) JP2004505621A (de)
AT (1) ATE360209T1 (de)
AU (2) AU2001281161B2 (de)
DE (1) DE60127965T2 (de)
ES (1) ES2284672T3 (de)
HK (1) HK1055462A1 (de)
WO (1) WO2002012900A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110609A1 (en) * 1998-12-28 2002-08-15 David Hung Increasing retrievable fluid from a breast duct
US6471660B1 (en) 1999-01-21 2002-10-29 Chandice Covington Method and apparatus for measuring factors in mammary fluids
AU769853B2 (en) * 1999-06-11 2004-02-05 Atossa Genetics, Inc. Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue
EP1307746B1 (de) * 2000-08-08 2007-04-18 Cytyc Corporation Nachweis viraler agentien in brustmilchkanälen und antivirale therapie
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
JP2008514900A (ja) 2004-07-30 2008-05-08 アデザ・バイオメデイカル・コーポレイシヨン 疾病および他の状態のマーカーとしての癌胎児性フィブロネクチンならびに癌胎児性フィブロネクチンの検出のための方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169774A (en) 1984-02-08 1992-12-08 Cetus Oncology Corporation Monoclonal anti-human breast cancer antibodies
JP3040121B2 (ja) 1988-01-12 2000-05-08 ジェネンテク，インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
IT1251542B (it) 1991-03-06 1995-05-17 D D S R L Dispositivo per il lavaggio a scopo terapeutico o di igiene di condotti interni del corpo umano o animale, che consente il drenaggio del liquido di lavaggio
US5763415A (en) * 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
US6221622B1 (en) 1998-04-28 2001-04-24 The Regents Of The University Of California Method and kit for obtaining fluids and cellular material from breast ducts
US6413228B1 (en) 1998-12-28 2002-07-02 Pro Duct Health, Inc. Devices, methods and systems for collecting material from a breast duct
US6638727B1 (en) 1999-01-26 2003-10-28 Cytyc Health Corporation Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
JP2003535617A (ja) * 1999-03-01 2003-12-02 プロ ダクト ヘルス インコーポレーティッド 多数の乳管に物質を同時に送達するための装置、方法、およびキット
EP1307746B1 (de) * 2000-08-08 2007-04-18 Cytyc Corporation Nachweis viraler agentien in brustmilchkanälen und antivirale therapie

Also Published As

Publication number Publication date
AU8116101A (en) 2002-02-18
EP1307746B1 (de) 2007-04-18
US20020045162A1 (en) 2002-04-18
US20070009946A1 (en) 2007-01-11
DE60127965D1 (de) 2007-05-31
ES2284672T3 (es) 2007-11-16
US7405045B2 (en) 2008-07-29
EP1307746A1 (de) 2003-05-07
HK1055462A1 (en) 2004-01-09
DE60127965T2 (de) 2007-12-20
JP2004505621A (ja) 2004-02-26
WO2002012900A1 (en) 2002-02-14
AU2001281161B2 (en) 2007-08-23
US7132232B2 (en) 2006-11-07

Similar Documents

Publication Publication Date Title
BR0111195A (pt) Uso de b-l-2'-desoxi-nucleosìdeos no tratamento de infecção por vìrus de hepatite delta
TR200002965T2 (tr) Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı
ATE500808T1 (de) Onkolytische virustherapie
CY2016021I2 (el) Στελεχη ιων για την ογκολυτικη θεραπεια του καρκινου
BR9913935A (pt) Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo
TR199903053T2 (xx) Benzimidazol t�revleri.
ATE131067T1 (de) Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei schweinen (prrs) und diagnose.
ATE245641T1 (de) Antivirale pyrimidinderivate
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
DE59001061D1 (de) Psoralen-reagens.
DK0745852T3 (da) Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
ATE360209T1 (de) Nachweis viraler agentien in brustmilchkanälen und antivirale therapie
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
DE60129358D1 (de) Genetische immunisierung gegen zervixkarzinom
NO20041855L (no) Fremgangsmate for behandling av hepatitt C-virusinfeksjon ved behandling av feilpasienter
EP1785727A3 (de) Identifizierung viraler Erreger in Brustgängen und Antivirustherapie dafür
PL348828A1 (en) New cancer treatments
PT948967E (pt) Tratamento de doencas virais em suicos
PT859613E (pt) Utilizacao de flupirtina para a profilaxia e o tratamento de doencas associadas a uma alteracao do sistema celular hematopoietico
FI963638A (fi) Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ATE356144T1 (de) Regulatorische/entfaltende peptide von ezrin
ATE232108T1 (de) Interleukin - 8 als antivirale- und antitumorwirkstoffe
BRPI0112407B8 (pt) uso de cepas de parapoxvírus ovis para produzir medicamentos antivirais e medicamentos contra câncer
ES2128322T3 (es) Peptidos que bloquean las infecciones debidas al virus de la inmunodeficiencia humana y procedimientos de utilizacion de estos peptidos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties